Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Marie Johnston
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

TTC Sponsors Key “The State of Clinical Development Costs” Conference in Philadelphia

% of readers think this story is Fact. Add your two cents.


PHILADELPHIA–(BUSINESS WIRE)–On January 11-12, 2011 TTC, llc, provider of industry-wide cost benchmarking tools, and the University of the Sciences in Philadelphia (USciences) sponsored the “The State of Clinical Development Costs” conference. Drawing eighty decision makers and specialists from a host of pharmaceutical, biotechnology and medical device companies, and CROs, the 2-day event included two keynote addresses, one by David Fairbrother, Director of Clinical Budgeting at Forest Laboratories, and Hani Zaki, Senior Vice President of PRA International, who spoke on “Future Challenges of Clinical Development; a View from the CRO.”

 The conference highlighted evidenced based decision-making and research findings. Proceeds from the conference are to be devoted to pursue evidence based research issues that arose during the session.

 News Facts:

    * TTC President and USciences Professor, Dr. Harold Glass calls “State of Clinical Development Costs” conference “another key step in maintaining a focus on managing clinical development costs, improving ROI and increasing compliance.”

    * TTC “State of Clinical Development” conference panels addressed a range of topics; “Effective Budgeting and Management of CRO Costs,” “Standard of Care Costs in Clinical Trials,” and “Compliance and Fair Market,” “Clinical Trial Costs in Emerging Geographies,” and “Standard of Care Costs in Clinical Trials.”

    * TTC conference heard an address from Dr. Patricia R. Audet, Chair, Department of Pharmaceutical and Healthcare Business, University of the Sciences. She spoke on “Productivity and Costs in Today’s HealthCare Arena.”

    * Dr. Laurence Poli of TTC presented on how CROs and sponsor companies have similar goals, but substantially different operational drivers. He highlighted ways to improve how the two types of organizations can work together once they better understand these differences.

Harold Glass, TTC Principal, and USciences Professor, summed up the conference, “The “State of Clinical Development” conference provided an excellent opportunity for pharmaceutical industry decision makers to learn how to manage and control clinical development costs, improve clinical ROI, and increase clinical compliance. We brought together some of the best thinkers in the industry and academia for two days of notable keynote addresses and one-on-one and panel discussions that covered the most up-to-date empirical research and experiences of leading edge companies.”

For more information on Clinical Trials visit http://www.ttc-llc.com or call us at +1-215.243.4103



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.